— Know what they know.
Not Investment Advice

ECOR NASDAQ

electroCore, Inc.
1W: -8.8% 1M: +6.6% 3M: +22.5% YTD: +122.9% 1Y: +105.3% 3Y: +73.0% 5Y: -41.7%
$10.14
-0.17 (-1.70%)
 
Weekly Expected Move ±7.6%
$9 $9 $10 $11 $12
NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 63 · $91.4M mcap · 5M float · 2.12% daily turnover · Short 38% of daily vol
Smart Money Score
Bullish 75
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$91.4M
52W Range4.41-12.7
Volume122,223
Avg Volume110,203
Beta1.01
Dividend—
Analyst Ratings
3 Buy 3 Hold 0 Sell
Consensus Buy
Company Info
CEOThomas J. Errico
Employees83
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-06-22
200 Forge Way
Rockaway, NJ 07866
US
973 290 0097
About electroCore, Inc.

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Recent Insider Trades

NameTypeSharesPriceDate
Errico Thomas J. P-Purchase 5,000 $9.82 2026-09-14
Fox Michael P-Purchase 5,000 $9.80 2026-09-11
Fox Michael A-Award 5,000 $9.80 2026-09-11
Wilber Patricia A-Award 11,123 — 2026-09-09
Bonfiglioli Elena A-Award 11,123 — 2026-09-09

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms